According to a recent "group commentary" by deans of medical research universities in the U.S., the threats of rising costs in research, reduced Federal support, and lower clinical revenue may have an impact on patient outcomes and the future of healthcare across the board.
Last month in Science Translational Medicine, a group commentary by administrators at several medical universities indicates that the reduction in proportional funding by Federal bodies like the National Institutes of Health means that universities are subsidizing more of the research that benefits patients, physicians, and medical care at large.
Additionally, the costs to comply with regulatory research requirements mean that universities are less inclined to plan for innovative scientific ventures, and the general environment may drive scientists from the field.
One such institution, the University of Utah, provides additional analysis and commentary.
“For university medical centers to continue to make the enormous strides in advancing research and helping people prevent and combat disease, the nation needs to invest in research,” said co-author, Vivian S. Lee, M.D., Ph.D., MBA, dean of the University of Utah’s School of Medicine, senior vice president of health sciences, and CEO of University of Utah Health Care. “As it stands already, university medical centers subsidize federally funded research. Moreover, universities have increasing administrative and bureaucratic burdens, and our clinical reimbursements, which have been used to help support research and teaching, are diminishing.”
Certainly researchers have been feeling the budgetary constraints for a while. Are you involved in medical research and have experienced the negative effects of reduced funding? Has the focus shifted away from research to revenue? Let us know in the comments!